Morphoceuticals

Morphoceuticals Inc. is a biotechnology company co-founded by Drs. Michael Levin and David Kaplan, with funding from Juvenescence Ltd. The company's core mission is to pioneer bioelectric approaches for limb regeneration and other regenerative medicine applications. Their vision is to harness the bioelectrome—the communication networks within the body—to reprogram anatomical programming for health and disease treatment. Morphoceuticals offers proprietary ion-based therapies aimed at inducing regeneration and maintaining tissue and organ integrity.

Notable affiliated individuals include co-founders Dr. Michael Levin, a leading expert in bioelectricity, and Dr. David Kaplan, a renowned figure in regenerative medicine. The company has garnered significant investment from Juvenescence Ltd., a prominent investor in longevity and biotechnology ventures. Key achievements include the development of the first atlas of the bioelectrome, positioning Morphoceuticals as a trailblazer in bioelectric solutions. Their innovative approach has the potential to revolutionize regenerative medicine and significantly impact healthcare outcomes.